India’s wealthiest billionaires have lost a staggering $30.5 billion (Rs 2.6 lakh crore) as stock market instability and ...

After falling 17 per cent since the start of the year to its March lows, the stock of the country’s largest pharmaceutical ...

The U.S. is preparing to announce sweeping tariffs on pharmaceutical imports within the next two months, according to ...

According to the USFDA, a Class II recall is issued when the use of or exposure to a violative product may cause temporary or ...

Glenmark, Sun Pharma, and Zydus are recalling various products in the US due to manufacturing issues and CGMP deviations, ...

Sun Pharmaceuticals is one of India’s largest pharmaceutical companies with over 8% share in the domestic market. It owns 35 ...

Karishma Shanghvi’s journey combines world-class education, a deep sense of purpose, and a passion for social change.

Michelle Xia represents a rising generation of biotech companies in China challenging Western giants.

A special congressional committee has recommended a $15 billion investment to boost the United States' biotech advantage over ...

Sun Pharmaceutical Industries Ltd. closed 13.91% short of its 52-week high of 1,960.20 rupees, which the company reached on September 30th.

Emkay Global maintains a 'Buy' rating on Sun Pharma after the US Court of Appeals vacates the injunction against Leqselvi's ...

The rise in the Sun Pharma share price came after a favourable ruling from a US court regarding its planned launch of ...